EUVIMEDAtklāt EUVIMED
Crossref

Post-Universal HBV Vaccination and Breakthrough Infections in Saudi Arabia: Three Decades of Evidence

Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh

Journal of Pioneering Medical Sciences · 2026-06-05 · 15 (5) · 167-177

DOI: 10.47310/jpms2026150522 ↗

At a glance

Journal article in Journal of Pioneering Medical Sciences, published online on 2026-06-05. Written by Shuaibu Abdullahi Hudu and 1 co-authors.

AbstraktsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

In Saudi Arabia, universal hepatitis B virus (HBV) vaccination was introduced in 1989, resulting in large declines in HBV endemicity over the last three decades. This structured narrative review evaluates the published evidence (1989-2025) on long-term vaccination outcomes, breakthrough infections, occult hepatitis B infection (OBI), and future elimination challenges in Saudi Arabia. Relevant studies were identified from PubMed, Scopus, Embase, Web of Science, and regional grey literature sources and narratively synthesized. Available evidence shows a decline in HBsAg prevalence from about 8% pre-universal vaccination to <1% in vaccine-era populations, confirming the significant public health impact of the national immunization program. However, HBV DNA positivity and occult infections are still being reported, particularly in blood donors, hemodialysis patients, healthcare workers, and other high-risk groups. Suggested contributors include waning of anti-HBs immunity, host immunogenetics, the predominance of genotype D, and vaccine-escape mutations. Current evidence also highlights important gaps in national molecular surveillance and sequencing data. While mass vaccination continues to be a very effective strategy for preventing chronic HBV infection, sustainable control will depend on improved molecular surveillance, targeted surveillance of high-risk groups, and evidence-based booster strategies. This review discusses the success of HBV vaccination in Saudi Arabia and the emerging post-immunization challenges pertinent to the goal of HBV elimination.

Cite

APA

Hudu, S. A., & Jimoh, A. O. (2026). Post-Universal HBV Vaccination and Breakthrough Infections in Saudi Arabia: Three Decades of Evidence. Journal of Pioneering Medical Sciences, 15(5), 167-177. https://doi.org/10.47310/jpms2026150522

Vancouver

Hudu SA, Jimoh AO. Post-Universal HBV Vaccination and Breakthrough Infections in Saudi Arabia: Three Decades of Evidence. Journal of Pioneering Medical Sciences. 2026;15(5):167-177. doi:10.47310/jpms2026150522

BibTeX
@article{Hudu2026,
  author = {Hudu, Shuaibu Abdullahi and Jimoh, Abdulgafar Olayiwola},
  title = {Post-Universal HBV Vaccination and Breakthrough Infections in Saudi Arabia: Three Decades of Evidence},
  journal = {Journal of Pioneering Medical Sciences},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {167--177},
  doi = {10.47310/jpms2026150522}
}
Start for free →